Statin-induced myopathy : a clinical perspective
Joint Authors
al-Sulayman, Abd al-Salam A.
al-Khamis, Fahd Ali
Source
Issue
Vol. 31, Issue 2 (30 Jun. 2009), pp.1-5, 5 p.
Publisher
King Hamad University Hospital
Publication Date
2009-06-30
Country of Publication
Bahrain
No. of Pages
5
Main Subjects
Abstract EN
Statins are at the forefront of treatments for hyperlipidemia, coronary artery disease and stroke.
Patients may not adhere to Statins therapy due to hepatic or neuromuscular side effects that include neuropathy and myopathy.
The latter include myalgia, lassitude, fatigue, proximal muscle weakness with or without elevated creatine kinase (CK) or myoglobinuria.
Studies suggest that these symptoms are under reported and may occur in as much as 5 % or more.
This article reviews the definition, incidence, possible mechanisms, risk factors, clinical presentation and suggested management of Statin-induced myopathy.
American Psychological Association (APA)
al-Sulayman, Abd al-Salam A.& al-Khamis, Fahd Ali. 2009. Statin-induced myopathy : a clinical perspective. Bahrain Medical Bulletin،Vol. 31, no. 2, pp.1-5.
https://search.emarefa.net/detail/BIM-601784
Modern Language Association (MLA)
al-Sulayman, Abd al-Salam A.& al-Khamis, Fahd Ali. Statin-induced myopathy : a clinical perspective. Bahrain Medical Bulletin Vol. 31, no. 2 (Jun. 2009), pp.1-5.
https://search.emarefa.net/detail/BIM-601784
American Medical Association (AMA)
al-Sulayman, Abd al-Salam A.& al-Khamis, Fahd Ali. Statin-induced myopathy : a clinical perspective. Bahrain Medical Bulletin. 2009. Vol. 31, no. 2, pp.1-5.
https://search.emarefa.net/detail/BIM-601784
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-601784